Group structure
8 companies in 2 countries
Loading…
8 companies in 2 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
22 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN, ASPIRIN AND CAFFEINE250mg; 250mg; 65mg · Tablet | Paracetamol, Acetylsalicylic acid, Caffeine | United States | Marketed | 2001 |
| ACETAMINOPHEN EXTRA STRENGTH RAPID RELEASE TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN EXTRA STRENGTH RED TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN EXTRA STRENGTH TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN REGULAR325 mg · Tablet | Paracetamol | Canada | Authorised | |
| AMPHETAMINE SULFATE10MG | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Amfetamine | United States | Marketed | 1984 |
| ARTHRITIS PAIN RELIEF650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2022 |
| BUTALBITAL AND ACETAMINOPHEN300mg; 50mg · Capsule | Paracetamol, Butalbital | United States | Marketed | 2017 |
| GABAPENTIN CAPSULES400 mg · Capsule | Gabapentin | Canada | Authorised | |
| GABAPENTIN CAPSULES300 mg · Capsule | Gabapentin | Canada | Authorised | |
| GABAPENTIN CAPSULES100 mg · Capsule | Gabapentin | Canada | Authorised | |
| GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE1.2gm; 120mg | 600mg; 60mg · Tablet, extended release | Guaifenesin, Pseudoephedrine | United States | Marketed | 2015 |
| IBUPROFEN100mg | 200mg | 300mg | 400mg | 600mg | 800mg · Tablet | Ibuprofen | United States | Marketed | 1985 |
| METFORMIN TABLETS850 mg · Tablet | Metformin | Canada | Marketed | 2022 |
| METFORMIN TABLETS500 mg · Tablet | Metformin | Canada | Marketed | 2022 |
| MUSCLE & BODY650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2025 |
| PENICILLAMINE250mg · Capsule | Penicillamine | United States | Marketed | 2019 |
| SILDENAFIL CITRATE10mg base/ml · For suspension | Sildenafil | United States | Marketed | 2019 |
| VIGABATRIN500mg/packet · For solution | Vigabatrin | United States | Marketed | 2017 |
| ZONISAMIDE100mg | 25mg | 50mg · Capsule | Zonisamide | United States | Marketed | 2005 |
| AMPHETAMINE10mg | 15mg | 20mg · Tablet, extended release | Amfetamine | United States | tentative | 2026 |
| AMPHETAMINE12.5mg | 15.7mg | 18.8mg | 3.1mg | 6.3mg | 9.4mg · Tablet, orally disintegrating | Amfetamine | United States | tentative | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 11 | 11 | 0 | CompaniesAll medicines |
| United States | 11 | 9 | 2 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM renovacion; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Report an error or request removalCorrections from the company itself are welcome.
Keep Granules’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.